首页 > 最新文献

Ethics & human research最新文献

英文 中文
Research Documents for Populations with Limited English Proficiency: Translation Approaches Matter 英语水平有限人群的研究文献:翻译方法的重要性
Q2 Social Sciences Pub Date : 2021-12-22 DOI: 10.1002/eahr.500115
Sonia Colina, Miriam Rodríguez-Guerra, Nicole Marrone, Maia Ingram, Karla J. Navarro, Genesis Arizmendi, Laura Coco

To avoid excluding individuals with limited English proficiency from participating in research, the consent form and other documents should be presented to them in their primary language and in a format that is understandable. However, evidence suggests that, when documents are translated for prospective and actual research participants with limited English proficiency, these individuals often fail to engage with the documents and the research in the same terms as their English-speaking counterparts do. We argue that this is because methodological challenges remain after a decision to translate has been made. This study investigated how translation approaches affected reader response and intelligibility. Participants were asked to review two translated versions of a survey (which reflected a functionalist and a literal approach to translation) followed by semistructured interviews. Quantitative and qualitative analysis revealed a preference for a functionalist translation and a higher number of problems raised in regard to the literal translation. The recommendations we offer here include considering the most appropriate translation approach for a specific genre and purpose.

为了避免将英语水平有限的个人排除在研究之外,同意书和其他文件应以他们的主要语言和可理解的格式提交给他们。然而,有证据表明,当文件被翻译给英语水平有限的潜在和实际的研究参与者时,这些人往往不能像他们的英语同行那样以同样的术语参与文件和研究。我们认为,这是因为在做出翻译决定后,方法论上的挑战仍然存在。本研究探讨了翻译方法对读者反应和可理解性的影响。参与者被要求阅读一份调查的两个翻译版本(反映了功能主义和字面翻译的方法),然后是半结构化的访谈。定量和定性分析表明,人们倾向于功能主义翻译,在直译方面提出了更多的问题。我们在这里提供的建议包括考虑针对特定类型和目的的最合适的翻译方法。
{"title":"Research Documents for Populations with Limited English Proficiency: Translation Approaches Matter","authors":"Sonia Colina,&nbsp;Miriam Rodríguez-Guerra,&nbsp;Nicole Marrone,&nbsp;Maia Ingram,&nbsp;Karla J. Navarro,&nbsp;Genesis Arizmendi,&nbsp;Laura Coco","doi":"10.1002/eahr.500115","DOIUrl":"10.1002/eahr.500115","url":null,"abstract":"<div>\u0000 \u0000 <p>To avoid excluding individuals with limited English proficiency from participating in research, the consent form and other documents should be presented to them in their primary language and in a format that is understandable. However, evidence suggests that, when documents are translated for prospective and actual research participants with limited English proficiency, these individuals often fail to engage with the documents and the research in the same terms as their English-speaking counterparts do. We argue that this is because methodological challenges remain after a decision to translate has been made. This study investigated how translation approaches affected reader response and intelligibility. Participants were asked to review two translated versions of a survey (which reflected a functionalist and a literal approach to translation) followed by semistructured interviews. Quantitative and qualitative analysis revealed a preference for a functionalist translation and a higher number of problems raised in regard to the literal translation. The recommendations we offer here include considering the most appropriate translation approach for a specific genre and purpose.</p>\u0000 </div>","PeriodicalId":36829,"journal":{"name":"Ethics & human research","volume":"44 1","pages":"29-39"},"PeriodicalIF":0.0,"publicationDate":"2021-12-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/eahr.500115","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39747690","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Biobank Participants’ Attitudes toward Requiring Understanding for Biobank Consent 生物样本库参与者对生物样本库同意书要求理解的态度
Q2 Social Sciences Pub Date : 2021-12-22 DOI: 10.1002/eahr.500114
T.J. Kasperbauer, Colin Halverson, Abigail Garcia, Karen K. Schmidt, Peter H. Schwartz

Biobank participants often do not understand the information they are provided during the informed consent process. Ethicists and other stakeholders have disagreed, however, on the appropriate response to these failures in understanding. This paper describes an attempt to address this issue by conducting knowledge tests with 22 recent biobank enrollees, followed by in-depth, semistructured interviews about the goal of understanding in biobank consent. The interviews revealed that while biobank enrollees thought the information on the knowledge test was important, they did not think that performance on the test should affect whether individuals are permitted to enroll in a biobank. Three main themes emerged from the interviews: helping others by contributing to research is more important than understanding consent forms, less understanding is required because biobank-based research is low risk, and only a small amount of information in the consent form is really essential. These perspectives should be considered in discussing the ethics and governance of biobank consent processes.

生物样本库的参与者通常不理解他们在知情同意过程中获得的信息。然而,伦理学家和其他利益相关者对这些理解失败的适当回应意见不一。本文描述了通过对22名最近的生物库登记者进行知识测试来解决这一问题的尝试,随后进行了深入的半结构化访谈,了解生物库同意的目标。访谈显示,虽然生物样本库的注册者认为知识测试中的信息很重要,但他们不认为在测试中的表现应该影响个人是否被允许注册生物样本库。访谈中出现了三个主要主题:通过为研究做出贡献来帮助他人比理解同意书更重要;由于基于生物库的研究风险较低,因此需要的理解较少;同意书中只有少量信息是真正必要的。在讨论生物库同意过程的伦理和治理时,应考虑这些观点。
{"title":"Biobank Participants’ Attitudes toward Requiring Understanding for Biobank Consent","authors":"T.J. Kasperbauer,&nbsp;Colin Halverson,&nbsp;Abigail Garcia,&nbsp;Karen K. Schmidt,&nbsp;Peter H. Schwartz","doi":"10.1002/eahr.500114","DOIUrl":"10.1002/eahr.500114","url":null,"abstract":"<div>\u0000 \u0000 <p>Biobank participants often do not understand the information they are provided during the informed consent process. Ethicists and other stakeholders have disagreed, however, on the appropriate response to these failures in understanding. This paper describes an attempt to address this issue by conducting knowledge tests with 22 recent biobank enrollees, followed by in-depth, semistructured interviews about the goal of understanding in biobank consent. The interviews revealed that while biobank enrollees thought the information on the knowledge test was important, they did not think that performance on the test should affect whether individuals are permitted to enroll in a biobank. Three main themes emerged from the interviews: helping others by contributing to research is more important than understanding consent forms, less understanding is required because biobank-based research is low risk, and only a small amount of information in the consent form is really essential. These perspectives should be considered in discussing the ethics and governance of biobank consent processes.</p>\u0000 </div>","PeriodicalId":36829,"journal":{"name":"Ethics & human research","volume":"44 1","pages":"18-28"},"PeriodicalIF":0.0,"publicationDate":"2021-12-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/eahr.500114","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39747689","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
The Ethical Implications of Big Data Research in Public Health: “Big Data Ethics by Design” in the UK-REACH Study 公共卫生大数据研究的伦理意义:英国reach研究中的“设计大数据伦理”
Q2 Social Sciences Pub Date : 2021-12-22 DOI: 10.1002/eahr.500111
Ruby Reed-Berendt, Edward S. Dove, Manish Pareek, UK-REACH Study Collaborative Group

In this article, we analyze legal and ethical issues raised in Big Data health research projects in the Covid-19 era and consider how these issues might be addressed in ways that advance positive values (e.g., furtherance of respect for persons and accordance with relevant legal frameworks) while mitigating or eliminating any negative aspects (e.g., exacerbation of social inequality and injustice). We apply this analysis specifically to UK-REACH (The United Kingdom Research Study into Ethnicity and Covid-19 Outcomes in Healthcare Workers), a project with which we are involved. We argue that Big Data projects like UK-REACH can be conducted in an ethically robust manner and that funders and sponsors ought to encourage similar projects to drive better evidence-based public policy in public health. As part of this, we advocate that a Big Data ethics-by-design approach be undertaken when such projects are constructed. This principle extends the work of those who advocate ethics by design by addressing prominent issues in Big Data health research projects; it holds that ethical values and principles in Big Data health research projects are best adhered to when they are already integrated into the project aims and methods at the design stage. In advocating this principle, we present a unique perspective regarding pressing ethical problems around large-scale, data-driven Covid-19 research, as well as legal issues associated with processing ostensibly anonymized health data.

在本文中,我们分析了Covid-19时代大数据健康研究项目中提出的法律和伦理问题,并考虑如何以促进积极价值观(例如,促进对人的尊重并遵守相关法律框架)的方式解决这些问题,同时减轻或消除任何负面影响(例如,加剧社会不平等和不公正)。我们专门将这一分析应用于UK-REACH(英国医疗工作者种族和Covid-19结果研究),这是我们参与的一个项目。我们认为,像UK-REACH这样的大数据项目可以在道德上稳健地进行,资助者和赞助商应该鼓励类似的项目,以推动更好的基于证据的公共卫生公共政策。作为其中的一部分,我们主张在建设此类项目时采用大数据设计伦理方法。这一原则通过解决大数据健康研究项目中的突出问题,扩展了那些倡导设计伦理的人的工作;认为在大数据健康研究项目中,伦理价值观和原则在设计阶段就已经融入到项目目标和方法中,是最能坚持的。在倡导这一原则的过程中,我们提出了一个独特的视角,来看待围绕大规模、数据驱动的Covid-19研究的紧迫伦理问题,以及与处理表面上匿名的健康数据相关的法律问题。
{"title":"The Ethical Implications of Big Data Research in Public Health: “Big Data Ethics by Design” in the UK-REACH Study","authors":"Ruby Reed-Berendt,&nbsp;Edward S. Dove,&nbsp;Manish Pareek,&nbsp;UK-REACH Study Collaborative Group","doi":"10.1002/eahr.500111","DOIUrl":"10.1002/eahr.500111","url":null,"abstract":"<div>\u0000 \u0000 <p>In this article, we analyze legal and ethical issues raised in Big Data health research projects in the Covid-19 era and consider how these issues might be addressed in ways that advance positive values (e.g., furtherance of respect for persons and accordance with relevant legal frameworks) while mitigating or eliminating any negative aspects (e.g., exacerbation of social inequality and injustice). We apply this analysis specifically to UK-REACH (The United Kingdom Research Study into Ethnicity and Covid-19 Outcomes in Healthcare Workers), a project with which we are involved. We argue that Big Data projects like UK-REACH can be conducted in an ethically robust manner and that funders and sponsors ought to encourage similar projects to drive better evidence-based public policy in public health. As part of this, we advocate that a <i>Big Data ethics-by-design</i> approach be undertaken when such projects are constructed. This principle extends the work of those who advocate ethics by design by addressing prominent issues in Big Data health research projects; it holds that ethical values and principles in Big Data health research projects are best adhered to when they are already integrated into the project aims and methods at the design stage. In advocating this principle, we present a unique perspective regarding pressing ethical problems around large-scale, data-driven Covid-19 research, as well as legal issues associated with processing ostensibly anonymized health data.</p></div>","PeriodicalId":36829,"journal":{"name":"Ethics & human research","volume":"44 1","pages":"2-17"},"PeriodicalIF":0.0,"publicationDate":"2021-12-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/eahr.500111","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9100521","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
How Scientists Perceive CRISPR's Translational Promise and the Implications for Individuals with Genetic Conditions 科学家如何看待CRISPR的转化前景及其对遗传疾病个体的影响
Q2 Social Sciences Pub Date : 2021-11-09 DOI: 10.1002/eahr.500108
Jodi Halpern, Sharon E. O'Hara, Aleksa L. Owen, David Paolo

CRISPR (clustered regularly interspaced short palindromic repeats) somatic genome editing, an important promissory technology, presents a case study of the movement of basic scientists into translational research. In this paper, we explore how scientists experience the pulls of CRISPR's power and the pushes of economic and societal pressures in adopting new translational roles. Given basic scientists' emerging contact with and influence upon individuals with genetic conditions, we also examine how scientists understand the perspectives of affected populations, both as potential subjects of early experiments and as the patients who could receive future treatments. Finally, we consider the ethical implications of our findings and call for innovative approaches to translational research that help scientists engage with people with genetic conditions in early translational research.

CRISPR(聚集规则间隔短回文重复序列)体细胞基因组编辑是一项重要的前景技术,是基础科学家转向转化研究的一个案例研究。在本文中,我们探讨了科学家在接受新的翻译角色时如何体验CRISPR的力量以及经济和社会压力的推动。考虑到基础科学家与遗传疾病个体的接触和影响,我们还研究了科学家如何理解受影响人群的观点,既可以作为早期实验的潜在受试者,也可以作为可能接受未来治疗的患者。最后,我们考虑了我们的研究结果的伦理意义,并呼吁采用创新的方法进行转化研究,帮助科学家在早期转化研究中与患有遗传疾病的人接触。
{"title":"How Scientists Perceive CRISPR's Translational Promise and the Implications for Individuals with Genetic Conditions","authors":"Jodi Halpern,&nbsp;Sharon E. O'Hara,&nbsp;Aleksa L. Owen,&nbsp;David Paolo","doi":"10.1002/eahr.500108","DOIUrl":"10.1002/eahr.500108","url":null,"abstract":"<p>CRISPR (clustered regularly interspaced short palindromic repeats) somatic genome editing, an important promissory technology, presents a case study of the movement of basic scientists into translational research. In this paper, we explore how scientists experience the pulls of CRISPR's power and the pushes of economic and societal pressures in adopting new translational roles. Given basic scientists' emerging contact with and influence upon individuals with genetic conditions, we also examine how scientists understand the perspectives of affected populations, both as potential subjects of early experiments and as the patients who could receive future treatments. Finally, we consider the ethical implications of our findings and call for innovative approaches to translational research that help scientists engage with people with genetic conditions in early translational research.</p>","PeriodicalId":36829,"journal":{"name":"Ethics & human research","volume":"43 6","pages":"28-41"},"PeriodicalIF":0.0,"publicationDate":"2021-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39709349","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An Approach to Reviewing Local Context for Exception from Informed Consent Trials Using a Single IRB 使用单一IRB审查知情同意试验例外的本地背景的方法
Q2 Social Sciences Pub Date : 2021-11-09 DOI: 10.1002/eahr.500109
Ann R. Johnson, Lisa M. Rigtrup, John VanBuren, Erin Rothwell, J. Michael Dean

In the context of emergency research, researchers can ask the institutional review board (IRB) to waive the regulatory requirement that individuals provide informed consent when enrolling in research studies. A requirement of the waiver of informed consent is that the reviewing IRB must review and approve a community consultation and public disclosure plan. It is critical that an IRB serving as the single IRB (sIRB) for multisite research be thoroughly versed in the local context concerns for each participating site to determine whether the site's community is being adequately consulted about the research in which individuals will be enrolled under an exception to the informed consent requirement. We designed an sIRB review model for evaluating site-specific community consultation plans that included a local evaluation and feedback step, and we piloted the model with a four-site, pediatric exception from informed consent (EFIC) clinical trial. We identified three key roles for the model: the sIRB, the investigators, and the representative of the institution's human research protection program (HRPP). We successfully collected the information and local input needed to evaluate each site's community consultation plan and applied the information to a thorough IRB review, despite the geographic distance between the study site and the sIRB.

在紧急研究的背景下,研究人员可以要求机构审查委员会(IRB)放弃个人在参加研究时提供知情同意的监管要求。豁免知情同意的一项要求是,审查委员会必须审查并批准社区咨询和公众披露计划。至关重要的是,作为多站点研究的单一IRB (sIRB)的IRB必须彻底了解每个参与站点的当地背景问题,以确定该站点的社区是否充分咨询了研究,个人将在知情同意要求的例外情况下被招募。我们设计了一个sIRB评估模型,用于评估特定地点的社区咨询计划,其中包括当地评估和反馈步骤,我们在一个四地点的儿科知情同意例外(EFIC)临床试验中对该模型进行了试点。我们确定了该模型的三个关键角色:sIRB、研究者和该机构人类研究保护计划(HRPP)的代表。我们成功地收集了评估每个站点的社区咨询计划所需的信息和本地输入,并将这些信息应用于彻底的IRB审查,尽管研究站点与sIRB之间存在地理距离。
{"title":"An Approach to Reviewing Local Context for Exception from Informed Consent Trials Using a Single IRB","authors":"Ann R. Johnson,&nbsp;Lisa M. Rigtrup,&nbsp;John VanBuren,&nbsp;Erin Rothwell,&nbsp;J. Michael Dean","doi":"10.1002/eahr.500109","DOIUrl":"10.1002/eahr.500109","url":null,"abstract":"<p>In the context of emergency research, researchers can ask the institutional review board (IRB) to waive the regulatory requirement that individuals provide informed consent when enrolling in research studies. A requirement of the waiver of informed consent is that the reviewing IRB must review and approve a community consultation and public disclosure plan. It is critical that an IRB serving as the single IRB (sIRB) for multisite research be thoroughly versed in the local context concerns for each participating site to determine whether the site's community is being adequately consulted about the research in which individuals will be enrolled under an exception to the informed consent requirement. We designed an sIRB review model for evaluating site-specific community consultation plans that included a local evaluation and feedback step, and we piloted the model with a four-site, pediatric exception from informed consent (EFIC) clinical trial. We identified three key roles for the model: the sIRB, the investigators, and the representative of the institution's human research protection program (HRPP). We successfully collected the information and local input needed to evaluate each site's community consultation plan and applied the information to a thorough IRB review, despite the geographic distance between the study site and the sIRB.</p>","PeriodicalId":36829,"journal":{"name":"Ethics & human research","volume":"43 6","pages":"42-48"},"PeriodicalIF":0.0,"publicationDate":"2021-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9928846","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Physician Perspectives on Including Pregnant Women in Covid-19 Clinical Trials: Time for a Paradigm Change 医生对将孕妇纳入新冠肺炎临床试验的看法:是时候改变范式了。
Q2 Social Sciences Pub Date : 2021-10-26 DOI: 10.1002/eahr.500107
Marie-Julie Trahan, Annabelle Cumyn, Matthew P. Cheng, Emily G. McDonald, Stephen E. Lapinsky, Nick Daneman, Haim A. Abenhaim, Isabelle Malhamé

Excluding pregnant people from Covid-19 clinical trials may lead to unintended harmful consequences. For this study, an online questionnaire was sent to physicians belonging to Canadian professional medical associations in order to evaluate their perspectives on the participation of pregnant women in Covid-19 clinical trials. The majority of respondents expressed support for including pregnant women in Covid-19 trials (119/165; 72%), especially those investigating therapies with a prior safety record in pregnancy (139/164; 85%). The main perceived barriers to inclusion identified were unwillingness of pregnant patients to participate and of treating teams to offer participation, the burden of regulatory approval, and a general “culture of exclusion” of pregnant women from trials. We describe why some physicians may be reluctant to include pregnant individuals in trials, and we identify barriers to the appropriate participation of pregnant people in clinical research.

将孕妇排除在新冠肺炎临床试验之外可能会导致意想不到的有害后果。在这项研究中,向加拿大专业医学协会的医生发送了一份在线问卷,以评估他们对孕妇参与新冠肺炎临床试验的看法。大多数受访者表示支持将孕妇纳入新冠肺炎试验(119/165;72%),尤其是那些调查有妊娠期安全记录的疗法的人(139/164;85%)。发现的纳入的主要障碍是孕妇不愿参与,治疗团队不愿参与,监管审批的负担,以及孕妇被排除在试验之外的普遍“文化”。我们描述了为什么一些医生可能不愿意将孕妇纳入试验,并确定了孕妇适当参与临床研究的障碍。
{"title":"Physician Perspectives on Including Pregnant Women in Covid-19 Clinical Trials: Time for a Paradigm Change","authors":"Marie-Julie Trahan,&nbsp;Annabelle Cumyn,&nbsp;Matthew P. Cheng,&nbsp;Emily G. McDonald,&nbsp;Stephen E. Lapinsky,&nbsp;Nick Daneman,&nbsp;Haim A. Abenhaim,&nbsp;Isabelle Malhamé","doi":"10.1002/eahr.500107","DOIUrl":"10.1002/eahr.500107","url":null,"abstract":"<div>\u0000 \u0000 <p>Excluding pregnant people from Covid-19 clinical trials may lead to unintended harmful consequences. For this study, an online questionnaire was sent to physicians belonging to Canadian professional medical associations in order to evaluate their perspectives on the participation of pregnant women in Covid-19 clinical trials. The majority of respondents expressed support for including pregnant women in Covid-19 trials (119/165; 72%), especially those investigating therapies with a prior safety record in pregnancy (139/164; 85%). The main perceived barriers to inclusion identified were unwillingness of pregnant patients to participate and of treating teams to offer participation, the burden of regulatory approval, and a general “culture of exclusion” of pregnant women from trials. We describe why some physicians may be reluctant to include pregnant individuals in trials, and we identify barriers to the appropriate participation of pregnant people in clinical research.</p>\u0000 </div>","PeriodicalId":36829,"journal":{"name":"Ethics & human research","volume":"43 6","pages":"19-27"},"PeriodicalIF":0.0,"publicationDate":"2021-10-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8652879/pdf/EAHR-43-19.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39562044","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Steps toward a System of IRB Precedent: Piloting Approaches to Summarizing IRB Decisions for Future Use 迈向IRB先例系统的步骤:总结IRB决策以供未来使用的试点方法
Q2 Social Sciences Pub Date : 2021-10-21 DOI: 10.1002/eahr.500106
Andrea Seykora, Carl Coleman, Stephen J. Rosenfeld, Barbara E. Bierer, Holly Fernandez Lynch

Institutional review boards (IRBs) have been criticized for inconsistency and lack of transparency in decision-making, problems that undermine both trust in their ability to protect human research participants and respect for their decisions among researchers. The absence of robust documentation of their decisions and the inability or unwillingness to share those decisions together represent a missed opportunity for IRBs to learn from one another and advance debates about challenging ethical issues. The concept of IRB precedent, modeled upon the system of legal precedent, has been proposed as a potential solution to these problems. In theory, an IRB faced with a review decision could look back at previous IRB decisions, either its own or those of other boards, made in similar studies or circumstances to guide the present decision. Some IRBs attempt this informally within their institution, but few examples of a structured system of IRB precedent have been described in the literature, and none has been widely adopted. This article describes a pilot project to summarize IRB decisions in a way that could facilitate their use as precedent by creating a documentation tool that meets four criteria—comprehensiveness, validity, searchability, and efficiency. Though this process turned out to be more challenging than expected, we identified key features of such a tool that holds promise for future development and could promote more consistent, robust IRB decision-making and advance discourse in human research ethics.

机构审查委员会(irb)因决策不一致和缺乏透明度而受到批评,这些问题既破坏了人们对它们保护人类研究参与者的能力的信任,也破坏了科学家对它们的决定的尊重。缺乏关于他们的决定的可靠文档,以及不能或不愿意一起分享这些决定,代表了irb错过了相互学习的机会,并推动了关于具有挑战性的道德问题的辩论。有人提出以法律先例制度为蓝本的IRB先例概念,作为解决这些问题的可能办法。理论上,面临审查决定的内部审查委员会可以回顾以前的内部审查委员会的决定,无论是自己的还是其他委员会的,在类似的研究或情况下做出的决定,以指导当前的决定。一些IRB在他们的机构内非正式地尝试这样做,但是在文献中很少有IRB先例的结构化系统的例子被描述,而且没有一个被广泛采用。本文描述了一个试点项目,通过创建一个满足四个标准——全面性、有效性、可搜索性和效率——的文档工具,以一种可以促进它们作为先例使用的方式来总结IRB决策。尽管这一过程比预期的更具挑战性,但我们确定了这种工具的关键特征,这些特征为未来的发展带来了希望,可以促进更一致、更有力的IRB决策,并推进人类研究伦理的讨论。
{"title":"Steps toward a System of IRB Precedent: Piloting Approaches to Summarizing IRB Decisions for Future Use","authors":"Andrea Seykora,&nbsp;Carl Coleman,&nbsp;Stephen J. Rosenfeld,&nbsp;Barbara E. Bierer,&nbsp;Holly Fernandez Lynch","doi":"10.1002/eahr.500106","DOIUrl":"10.1002/eahr.500106","url":null,"abstract":"<p>Institutional review boards (IRBs) have been criticized for inconsistency and lack of transparency in decision-making, problems that undermine both trust in their ability to protect human research participants and respect for their decisions among researchers. The absence of robust documentation of their decisions and the inability or unwillingness to share those decisions together represent a missed opportunity for IRBs to learn from one another and advance debates about challenging ethical issues. The concept of <i>IRB precedent</i>, modeled upon the system of legal precedent, has been proposed as a potential solution to these problems. In theory, an IRB faced with a review decision could look back at previous IRB decisions, either its own or those of other boards, made in similar studies or circumstances to guide the present decision. Some IRBs attempt this informally within their institution, but few examples of a structured system of IRB precedent have been described in the literature, and none has been widely adopted. This article describes a pilot project to summarize IRB decisions in a way that could facilitate their use as precedent by creating a documentation tool that meets four criteria—comprehensiveness, validity, searchability, and efficiency. Though this process turned out to be more challenging than expected, we identified key features of such a tool that holds promise for future development and could promote more consistent, robust IRB decision-making and advance discourse in human research ethics.</p>","PeriodicalId":36829,"journal":{"name":"Ethics & human research","volume":"43 6","pages":"2-18"},"PeriodicalIF":0.0,"publicationDate":"2021-10-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39541198","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Creating a Research Ethics Consultation Service: Issues to Consider 创建研究伦理咨询服务:需要考虑的问题
Q2 Social Sciences Pub Date : 2021-09-08 DOI: 10.1002/eahr.500101
Holly A. Taylor, Kathryn M. Porter, Erin Talati Paquette, Jennifer B. McCormick, Emma Tumilty, Jason F. Arnold, Kayte Spector-Bagdady, Marion Danis, Debra Brandt, Jina Shah, Benjamin S. Wilfond, Lisa M. Lee

This article provides pragmatic advice for organizations interested in creating a research ethics consultation service (RECS). A robust RECS has the potential to build capacity among investigators to identify and consider the ethical issues they encounter while conducting their research. Determining whether to establish an RECS should begin with an institutional-needs assessment that includes three key questions: What are the current resources available to research teams to navigate ethical concerns that arise from their research? Is there a demand or perceived need for more resources? Is there institutional support (financial and otherwise) to establish and maintain an RECS? If this results in the decision to establish the consultation service, relevant institutional stakeholders must be identified and consulted, and personnel with the requisite skills recruited. The next step is to establish an RECS and build the infrastructure to process and respond to requests. The RECS's long-term sustainability will depend on a stable source of funding and a mechanism to receive constructive feedback to ensure that the service is meeting the institutional needs it set out to address.

本文为有兴趣创建研究伦理咨询服务(RECS)的组织提供了实用的建议。一个强大的RECS有可能在研究人员中建立能力,以识别和考虑他们在进行研究时遇到的伦理问题。决定是否建立RECS应该从机构需求评估开始,包括三个关键问题:研究团队目前有哪些可用资源来处理他们研究中出现的伦理问题?是否存在对更多资源的需求或感知需求?是否有机构支持(财政和其他方面)来建立和维持区域经济合作体系?如果这导致决定建立咨询服务,则必须确定和咨询相关的机构利益相关者,并招聘具有必要技能的人员。下一步是建立RECS并构建处理和响应请求的基础设施。RECS的长期可持续性将取决于稳定的资金来源和接受建设性反馈的机制,以确保该服务满足其着手解决的机构需求。
{"title":"Creating a Research Ethics Consultation Service: Issues to Consider","authors":"Holly A. Taylor,&nbsp;Kathryn M. Porter,&nbsp;Erin Talati Paquette,&nbsp;Jennifer B. McCormick,&nbsp;Emma Tumilty,&nbsp;Jason F. Arnold,&nbsp;Kayte Spector-Bagdady,&nbsp;Marion Danis,&nbsp;Debra Brandt,&nbsp;Jina Shah,&nbsp;Benjamin S. Wilfond,&nbsp;Lisa M. Lee","doi":"10.1002/eahr.500101","DOIUrl":"10.1002/eahr.500101","url":null,"abstract":"<p>This article provides pragmatic advice for organizations interested in creating a research ethics consultation service (RECS). A robust RECS has the potential to build capacity among investigators to identify and consider the ethical issues they encounter while conducting their research. Determining whether to establish an RECS should begin with an institutional-needs assessment that includes three key questions: What are the current resources available to research teams to navigate ethical concerns that arise from their research? Is there a demand or perceived need for more resources? Is there institutional support (financial and otherwise) to establish and maintain an RECS? If this results in the decision to establish the consultation service, relevant institutional stakeholders must be identified and consulted, and personnel with the requisite skills recruited. The next step is to establish an RECS and build the infrastructure to process and respond to requests. The RECS's long-term sustainability will depend on a stable source of funding and a mechanism to receive constructive feedback to ensure that the service is meeting the institutional needs it set out to address.</p>","PeriodicalId":36829,"journal":{"name":"Ethics & human research","volume":"43 5","pages":"18-25"},"PeriodicalIF":0.0,"publicationDate":"2021-09-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/eahr.500101","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39395649","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
A Call for Better, Not Faster, Research Ethics Committee Reviews in the Covid-19 Era 呼吁在Covid-19时代进行更好而不是更快的研究伦理委员会审查
Q2 Social Sciences Pub Date : 2021-09-08 DOI: 10.1002/eahr.500104
Leonardo Tamariz, Fred J. Hendler, John M. Wells, Annette Anderson, Stephen Bartlett

With the rapid spread of SARS-CoV2 has come a rapid proliferation of clinical research studies, resulting in considerable strain on research ethics committees (RECS), which need to review study proposals. RECs are pressured to move through the review process quickly so that studies can get underway to address the pandemic. These committees are also asked to increase efficiency without relaxing the standards for ethical review. RECs are accustomed to external pressure for approval from investigators; however, in the Covid-19 era, this pressure is coming from not only the sponsors and investigators but also many other stakeholders, including world leaders, the community, the media, and professional organizations. Drawing on the authors' experiences on a central REC reviewing complex multicenter Covid-19 studies, this commentary describes challenges that are inherent to Covid-19 research studies, such as the difficulty of obtaining informed consent from patients ill with the highly infectious virus. The commentary recommends several steps that RECs can take to ensure ethical review of research studies during the Covid-19 pandemic and future infectious disease outbreaks.

随着SARS-CoV2的迅速传播,临床研究的迅速增加,给需要审查研究提案的研究伦理委员会(RECS)带来了相当大的压力。RECs面临着迅速通过审查程序的压力,以便能够开展研究以应对大流行。这些委员会还被要求在不放松伦理审查标准的情况下提高效率。RECs习惯于外部压力来获得调查人员的批准;然而,在Covid-19时代,这种压力不仅来自赞助商和调查人员,还来自许多其他利益攸关方,包括世界领导人、社区、媒体和专业组织。根据作者在中央REC审查复杂的多中心Covid-19研究的经验,本评论描述了Covid-19研究固有的挑战,例如难以从患有高传染性病毒的患者那里获得知情同意。该评论建议,在2019冠状病毒病大流行和未来传染病暴发期间,研究委员会可采取若干步骤,确保对研究进行伦理审查。
{"title":"A Call for Better, Not Faster, Research Ethics Committee Reviews in the Covid-19 Era","authors":"Leonardo Tamariz,&nbsp;Fred J. Hendler,&nbsp;John M. Wells,&nbsp;Annette Anderson,&nbsp;Stephen Bartlett","doi":"10.1002/eahr.500104","DOIUrl":"10.1002/eahr.500104","url":null,"abstract":"<div>\u0000 \u0000 <p>With the rapid spread of SARS-CoV2 has come a rapid proliferation of clinical research studies, resulting in considerable strain on research ethics committees (RECS), which need to review study proposals. RECs are pressured to move through the review process quickly so that studies can get underway to address the pandemic. These committees are also asked to increase efficiency without relaxing the standards for ethical review. RECs are accustomed to external pressure for approval from investigators; however, in the Covid-19 era, this pressure is coming from not only the sponsors and investigators but also many other stakeholders, including world leaders, the community, the media, and professional organizations. Drawing on the authors' experiences on a central REC reviewing complex multicenter Covid-19 studies, this commentary describes challenges that are inherent to Covid-19 research studies, such as the difficulty of obtaining informed consent from patients ill with the highly infectious virus. The commentary recommends several steps that RECs can take to ensure ethical review of research studies during the Covid-19 pandemic and future infectious disease outbreaks.</p>\u0000 </div>","PeriodicalId":36829,"journal":{"name":"Ethics & human research","volume":"43 5","pages":"42-44"},"PeriodicalIF":0.0,"publicationDate":"2021-09-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/eahr.500104","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39413351","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
Making Metrics Meaningful: How Human Research Protection Programs Can Efficiently and Effectively Use Their Data 使指标有意义:人类研究保护计划如何有效地使用他们的数据
Q2 Social Sciences Pub Date : 2021-09-08 DOI: 10.1002/eahr.500102
Kimberley Serpico

Human research protection programs (HRPP) generate an abundance of data on performance, capacity, and compliance. When used effectively, this information can be instrumental in helping HRPPs meet programmatic and institutional goals, demonstrate growth and success, and improve the HRPP overall. Metrics must be grounded in professional insight so that HRPPs can pair analytics with strategies for future action or improvement. The purpose of this paper is to demonstrate how high-performing HRPPs develop, adopt, and implement a metrics framework that benefits everyday operations and produces real-world results. Through a three-part thematic framework (of insight, data, and action) and by providing case examples and actionable strategies, this article will address how HRPPs iteratively develop and characterize their metrics, build a metrics framework that leverages both quantitative and qualitative data to validate outcomes, and activate human insight to produce meaningful communication, visualization, and dissemination of data.

人类研究保护计划(HRPP)生成了大量关于性能、容量和遵从性的数据。如果有效使用,这些信息可以帮助HRPP实现计划和机构目标,展示增长和成功,并整体改善HRPP。指标必须建立在专业见解的基础上,这样hrpp才能将分析与未来行动或改进的策略结合起来。本文的目的是演示高性能hrpp如何开发、采用和实现有利于日常操作并产生实际结果的度量框架。通过一个由三部分组成的主题框架(洞察力、数据和行动),并通过提供案例和可操作的策略,本文将讨论hrpp如何迭代地开发和描述他们的指标,构建一个利用定量和定性数据来验证结果的指标框架,并激活人类洞察力来产生有意义的交流、可视化和数据传播。
{"title":"Making Metrics Meaningful: How Human Research Protection Programs Can Efficiently and Effectively Use Their Data","authors":"Kimberley Serpico","doi":"10.1002/eahr.500102","DOIUrl":"10.1002/eahr.500102","url":null,"abstract":"<p>Human research protection programs (HRPP) generate an abundance of data on performance, capacity, and compliance. When used effectively, this information can be instrumental in helping HRPPs meet programmatic and institutional goals, demonstrate growth and success, and improve the HRPP overall. Metrics must be grounded in professional insight so that HRPPs can pair analytics with strategies for future action or improvement. The purpose of this paper is to demonstrate how high-performing HRPPs develop, adopt, and implement a metrics framework that benefits everyday operations and produces real-world results. Through a three-part thematic framework (of insight, data, and action) and by providing case examples and actionable strategies, this article will address how HRPPs iteratively develop and characterize their metrics, build a metrics framework that leverages both quantitative and qualitative data to validate outcomes, and activate human insight to produce meaningful communication, visualization, and dissemination of data.</p>","PeriodicalId":36829,"journal":{"name":"Ethics & human research","volume":"43 5","pages":"26-35"},"PeriodicalIF":0.0,"publicationDate":"2021-09-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1002/eahr.500102","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39395650","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
期刊
Ethics & human research
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1